Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: TAUNS Laboratories,Inc.

Market Cap 51.67B 323M 279M 257M 240M 450M 30.66B 457M 3.03B 1.18B 14.92B 1.21B 1.18B P/E Ratio 2025
8.67x
P/E Ratio 2026 * 9.75x
Enterprise Value 58.5B 365M 315M 291M 272M 510M 34.71B 518M 3.43B 1.34B 16.9B 1.37B 1.34B EV / Sales 2025
3.23x
EV / Sales 2026 * 4.04x
Free-Float
29.8%
Yield 2025
5.2%
Yield 2026 * 7.27%
1 day-0.21%
1 week-0.82%
Current month-2.22%
1 month-4.90%
3 months-10.19%
6 months-3.77%
Current year-4.72%
1 week 484
Extreme 484
492
1 month 484
Extreme 484
509
Current year 484
Extreme 484
568
1 year 484
Extreme 484
603
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 2014-04-30
Director of Finance/CFO 66 2018-10-31
Corporate Officer/Principal 38 2022-06-30
Director TitleAgeSince
Director/Board Member 51 2014-04-30
Director/Board Member 66 2020-08-31
Director/Board Member 52 2016-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-0.82%-17.52% - 323M
-0.17%+3.67%+165.65%+274.95% 17.36B
-1.74%-7.00%-44.69%-25.52% 9.37B
-0.19%+3.10%+29.91%+23.97% 6.79B
-0.47%+8.19% - - 5.09B
-0.39%+0.21%-31.90%-24.73% 5.07B
-2.92%-6.89%-29.54%-31.71% 4.18B
-1.36%-17.61%+62.18%+48.54% 3.81B
-0.71%-7.76%+170.60%-48.74% 3.69B
+0.64%+2.22%-19.35%-42.41% 2.62B
Average -0.76%-3.04%+31.71%+21.79% 5.83B
Weighted average by Cap. -0.75%-2.87%+59.83%+81.90%

Financials

2025 2026 *
Net sales 19.06B 119M 103M 94.7M 88.64M 166M 11.31B 169M 1.12B 436M 5.5B 447M 437M 14.76B 92.12M 79.56M 73.31M 68.63M 129M 8.76B 131M 866M 338M 4.26B 346M 338M
Net income 6.5B 40.57M 35.04M 32.29M 30.23M 56.65M 3.86B 57.53M 381M 149M 1.88B 152M 149M 5.2B 32.47M 28.04M 25.84M 24.19M 45.33M 3.09B 46.04M 305M 119M 1.5B 122M 119M
Net Debt 6.83B 42.63M 36.82M 33.93M 31.76M 59.52M 4.05B 60.44M 401M 156M 1.97B 160M 157M 7.99B 49.9M 43.1M 39.72M 37.18M 69.67M 4.74B 70.75M 469M 183M 2.31B 187M 183M
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
26-06-12 485.00 ¥ -0.21% 219,200
26-06-11 486.00 ¥ -0.41% 216,800
26-06-10 488.00 ¥ -0.20% 197,500
26-06-09 489.00 ¥ -0.20% 89,400
26-06-08 490.00 ¥ 0.00% 124,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
485.00JPY
Average target price
420.00JPY
Spread / Average Target
-13.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 197A Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!